UA95497C2 - Antidiabetogenic calcium-peptide composition - Google Patents
Antidiabetogenic calcium-peptide compositionInfo
- Publication number
- UA95497C2 UA95497C2 UAA200905665A UAA200905665A UA95497C2 UA 95497 C2 UA95497 C2 UA 95497C2 UA A200905665 A UAA200905665 A UA A200905665A UA A200905665 A UAA200905665 A UA A200905665A UA 95497 C2 UA95497 C2 UA 95497C2
- Authority
- UA
- Ukraine
- Prior art keywords
- calcium
- antidiabetogenic
- peptide composition
- diabetes
- type
- Prior art date
Links
- 230000002098 anti-diabetogenic effect Effects 0.000 title abstract 2
- 108010067454 caseinomacropeptide Proteins 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to the use of a calcium-peptide composition obtained from at least one calcium salt, at least one caseinophosphopeptide (CPP), and/or at least one glycomacropeptide (GMP) for producing an agent for preventing and/or treating type II diabetes. Administering said composition makes it possible to significantly suppress the onset of type II diabetes (antidiabetogenic effect).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006052560A DE102006052560B4 (en) | 2006-11-06 | 2006-11-06 | Anti-diabetogenic calcium peptide composition |
Publications (1)
Publication Number | Publication Date |
---|---|
UA95497C2 true UA95497C2 (en) | 2011-08-10 |
Family
ID=39148568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200905665A UA95497C2 (en) | 2006-11-06 | 2007-10-29 | Antidiabetogenic calcium-peptide composition |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2089046A2 (en) |
DE (1) | DE102006052560B4 (en) |
EA (1) | EA016545B1 (en) |
UA (1) | UA95497C2 (en) |
WO (1) | WO2008055801A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846612B2 (en) | 2009-04-03 | 2014-09-30 | Nestec S.A. | Promotion of healthy catch-up growth |
CN109846901A (en) * | 2019-04-03 | 2019-06-07 | 江西安顺堂生物科技有限公司 | It is a kind of to promote bone growth, anti-caries, the preparation and preparation process for supplementing calcium |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL176042C (en) * | 1978-11-13 | 1985-02-18 | Cca Biochem B V | METHOD FOR PREPARING AERIAL CONTAINERS FOR DIABETICIANS. |
GB9927603D0 (en) * | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
US6207638B1 (en) * | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
US6384087B1 (en) * | 2000-09-01 | 2002-05-07 | University Of Tennesseee Research Corporation, Inc. | Materials and methods for the treatment or prevention of obesity |
GB0100273D0 (en) * | 2001-01-08 | 2001-02-14 | Nestle Sa | Nutritional composition for a bone condition |
US20030165574A1 (en) * | 2002-03-01 | 2003-09-04 | Ward Loren Spencer | Compositions and methods for treatment of body weight conditions |
CN1395870A (en) * | 2002-07-25 | 2003-02-12 | 徐佳立 | Hypoglycemic health-care polypeptide food |
KR100577677B1 (en) * | 2003-06-25 | 2006-05-10 | (주)현덕비엔티 | Composition for lowering blood glucose |
DE102005033630A1 (en) * | 2005-07-19 | 2007-01-25 | Humana Gmbh | Calcium-peptide component |
-
2006
- 2006-11-06 DE DE102006052560A patent/DE102006052560B4/en not_active Expired - Fee Related
-
2007
- 2007-10-29 UA UAA200905665A patent/UA95497C2/en unknown
- 2007-10-29 WO PCT/EP2007/061611 patent/WO2008055801A2/en active Application Filing
- 2007-10-29 EA EA200970441A patent/EA016545B1/en not_active IP Right Cessation
- 2007-10-29 EP EP07847082A patent/EP2089046A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA016545B1 (en) | 2012-05-30 |
EP2089046A2 (en) | 2009-08-19 |
DE102006052560B4 (en) | 2010-01-21 |
WO2008055801A2 (en) | 2008-05-15 |
WO2008055801A3 (en) | 2008-12-04 |
EA200970441A1 (en) | 2009-12-30 |
DE102006052560A1 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009000657A (en) | Compositions and methods for the treatment of mucositis. | |
TW200732296A (en) | Novel compounds | |
MX2007002398A (en) | New pharmaceutical compositions for the treatment of cancer. | |
WO2008097640A8 (en) | Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer | |
TW200745003A (en) | Novel compounds | |
TW200612892A (en) | Novel compounds | |
WO2009026179A3 (en) | Antiinfective proanthocyanidin compounds and methods of use thereof | |
MX2007005590A (en) | Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof. | |
WO2007139955A3 (en) | Triazole compounds that modulate hsp90 activity | |
WO2007139967A3 (en) | Triazole compounds that modulate hsp90 activity | |
JO2686B1 (en) | compounds | |
TW200630336A (en) | Novel compounds | |
MY150702A (en) | Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them | |
TW200621690A (en) | Novel compounds | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
TW200731974A (en) | Transdermal system for verenicline | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
TW200700071A (en) | Novel use | |
CL2011000933A1 (en) | The compound 2 - [(5-chloro-2 - {[3-methyl-1- (1-methyl ethyl) -1h-pyrazol-5-yl] amino} -4-pyridinyl) amino] -n- (methyloxy) benzamide and its salts, focal adhesion kinase inhibitor (fak); pharmaceutical composition that includes it; and its use for the treatment of cancer. | |
IL193252A0 (en) | N-hydroxyacrylamide compounds | |
WO2008073332A3 (en) | Creatine compositions for skin treatment | |
TW200742580A (en) | Methods for treating nephrolithiasis | |
CL2008003933A1 (en) | Compounds derived from n-heterocyclo- [1,2-a] -pyridine-2-carboxamide; preparation procedure; pharmaceutical composition; Useful in the treatment and / or prevention of neurodegenerative and inflammatory diseases, epilepsy, osteoporosis, malignant tumors, among others. | |
HRP20080422T3 (en) | Satraplatin for treating resistant or refractory tumors | |
UA95497C2 (en) | Antidiabetogenic calcium-peptide composition |